The Therapeutic Goods Administration has updated its advice on a possible shortage of Pegasys in Australia. Its website now states that there is an anticipated shortage from June to September 2025.

To date, prompt action by the supplier of Pegasys in Australia, Echo Therapeutics in partnership with JustMeds, has enabled Australian patients to continue to access Pegasys despite the worldwide shortage.

Echo Therapeutics has written a letter to MPN patients providing more context about the shortage and its likely duration, what is being done to minimise the shortage, etc.
See: Letter-to-Patients-Update-on-Pegasys®-supply-Australia-March-2025.

As to where to from here for MPN patients being treated with Pegasys…..
Valuable information and strategies for patients to discuss with their haematologist are outlined in the Q and A video interview below with haematologist Dr Cecily Forsyth and MPN AA team member and advocate Nathalie Cook OAM.

Multidosing information

During the period of the anticipated Pegasys shortage, some patients may wish to know how some of us multidose from a pegasys vial.  A video has kindly been prepared by haematology nurse practitioner, Jacqui Jagger to provide patients with information on how this can be done safely and effectively (see below).

An information sheet on multidosing has also been prepared – see How some patients multidose.

For future updates, please continue to check the News section of this website.